SymBio Pharmaceuticals Limited SYMQY

Set alert

Price alert · SYMQY

All alert types
0.28 USD -0.09 -23.34%

At close · Oct 30

0.3659 Day range 0.3659
0.2805 52-week range 0.85275
YTD
-55.97%
1 year
-67.11%
Open
0.3659
Prev close
0.3659
Mkt cap
22.48M
Vol
2.50K
Avg vol
78
EPS
-0.63
P/E
0.00
More statistics
Low
0.3659
High
0.3659

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for SYMQY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-85.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.0×
FY 2016: -1.2×FY 2017: -0.9×FY 2018: -1.6×FY 2019: -1.4×FY 2020: -2.0×FY 2021: 5.3×FY 2022: 22.4×FY 2023: -4.9×FY 2024: -2.3×FY 2025: -1.0×
FY 2016 5y median -1.0× FY 2025
P/S 3.7×
FY 2016: 1.2×FY 2017: 1.0×FY 2018: 1.2×FY 2019: 2.2×FY 2020: 2.8×FY 2021: 1.3×FY 2022: 2.6×FY 2023: 1.7×FY 2024: 3.5×FY 2025: 3.7×
FY 2016 5y median 2.6× FY 2025
P/B 3.9×
FY 2016: 0.5×FY 2017: 1.1×FY 2018: 0.9×FY 2019: 1.4×FY 2020: 1.8×FY 2021: 1.6×FY 2022: 3.1×FY 2023: 1.3×FY 2024: 2.1×FY 2025: 3.9×
FY 2016 5y median 2.1× FY 2025
P/FCF -1.0×
FY 2016: -1.4×FY 2017: -0.9×FY 2018: -1.9×FY 2019: -1.3×FY 2020: -2.0×FY 2021: 142×FY 2022: 16.8×FY 2023: -22.4×FY 2024: -2.5×FY 2025: -1.0×
FY 2016 5y median -1.0× FY 2025
EV/EBITDA -0.9×
FY 2016: 1.2×FY 2017: -0.1×FY 2018: 0.1×FY 2019: -0.5×FY 2020: -1.0×FY 2021: 6.3×FY 2022: 9.7×FY 2023: -4.3×FY 2024: -1.2×FY 2025: -0.9×
FY 2016 5y median -0.9× FY 2025
EV/Sales 3.0×
FY 2016: -1.0×FY 2017: 0.1×FY 2018: -0.1×FY 2019: 0.8×FY 2020: 1.5×FY 2021: 0.8×FY 2022: 2.0×FY 2023: 0.5×FY 2024: 1.9×FY 2025: 3.0×
FY 2016 5y median 1.9× FY 2025
FCF Yield -95.6%
FY 2016: -70.5%FY 2017: -112.7%FY 2018: -52.9%FY 2019: -74.1%FY 2020: -51.2%FY 2021: 0.7%FY 2022: 5.9%FY 2023: -4.5%FY 2024: -39.9%FY 2025: -95.6%
FY 2016 5y median -4.5% FY 2025

Profitability

Gross Margin 72.4%
FY 2016: 38.2%FY 2017: 29.9%FY 2018: 30.6%FY 2019: 30.5%FY 2020: 29.0%FY 2021: 70.3%FY 2022: 75.9%FY 2023: 78.9%FY 2024: 76.4%FY 2025: 72.4%
FY 2016 5y median 75.9% FY 2025
Operating Margin -339.6%
FY 2016: -89.8%FY 2017: -114.6%FY 2018: -69.2%FY 2019: -151.6%FY 2020: -150.9%FY 2021: 12.3%FY 2022: 19.6%FY 2023: -14.5%FY 2024: -158.1%FY 2025: -339.6%
FY 2016 5y median -14.5% FY 2025
Net Margin -365.3%
FY 2016: -97.7%FY 2017: -115.5%FY 2018: -71.8%FY 2019: -154.2%FY 2020: -136.9%FY 2021: 24.6%FY 2022: 11.8%FY 2023: -35.1%FY 2024: -156.3%FY 2025: -365.3%
FY 2016 5y median -35.1% FY 2025
ROE -393.4%
FY 2016: -42.2%FY 2017: -122.8%FY 2018: -56.2%FY 2019: -99.5%FY 2020: -87.8%FY 2021: 30.1%FY 2022: 13.9%FY 2023: -27.2%FY 2024: -91.3%FY 2025: -393.4%
FY 2016 5y median -27.2% FY 2025
ROIC -142.7%
FY 2016: -35.8%FY 2017: -121.8%FY 2018: -54.2%FY 2019: -97.7%FY 2020: -96.7%FY 2021: 14.7%FY 2022: 12.9%FY 2023: -11.3%FY 2024: -92.3%FY 2025: -142.7%
FY 2016 5y median -11.3% FY 2025
ROA -129.4%
FY 2016: -33.6%FY 2017: -93.5%FY 2018: -44.1%FY 2019: -83.0%FY 2020: -65.2%FY 2021: 24.0%FY 2022: 11.3%FY 2023: -24.0%FY 2024: -77.2%FY 2025: -129.4%
FY 2016 5y median -24.0% FY 2025

Growth (YoY)

Revenue -44.1%
FY 2016: 22.5%FY 2017: 45.4%FY 2018: 11.4%FY 2019: -26.0%FY 2020: 5.3%FY 2021: 176.3%FY 2022: 21.3%FY 2023: -44.1%FY 2024: -56.1%FY 2025: -44.1%
FY 2016 FY 2025
Operating Income -20.1%
FY 2016: 16.6%FY 2017: -85.6%FY 2018: 32.7%FY 2019: -62.0%FY 2020: -4.8%FY 2021: 122.5%FY 2022: 93.3%FY 2023: -141.3%FY 2024: -377.7%FY 2025: -20.1%
FY 2016 FY 2025
EPS (diluted) -18.6%
FY 2016: 27.6%FY 2017: -35.6%FY 2018: 48.1%FY 2019: -14.2%FY 2020: 34.3%FY 2021: 142.1%FY 2022: -43.1%FY 2023: -265.2%FY 2024: -70.9%FY 2025: -18.6%
FY 2016 FY 2025
Free Cash Flow -38.5%
FY 2016: 13.4%FY 2017: -94.9%FY 2018: 39.0%FY 2019: -93.2%FY 2020: 6.5%FY 2021: 101.8%FY 2022: 1955.9%FY 2023: -127.3%FY 2024: -710.2%FY 2025: -38.5%
FY 2016 FY 2025

Financial Health

Current Ratio 3.0×
FY 2016: 7.1×FY 2017: 4.0×FY 2018: 4.5×FY 2019: 5.6×FY 2020: 3.6×FY 2021: 4.4×FY 2022: 4.8×FY 2023: 8.4×FY 2024: 6.4×FY 2025: 3.0×
FY 2016 5y median 4.8× FY 2025
Quick Ratio 2.7×
FY 2016: 6.8×FY 2017: 3.6×FY 2018: 4.1×FY 2019: 5.6×FY 2020: 3.0×FY 2021: 4.2×FY 2022: 4.6×FY 2023: 8.2×FY 2024: 6.1×FY 2025: 2.7×
FY 2016 5y median 4.6× FY 2025
Debt / Equity 1.6×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 1.6×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 2.5×FY 2017: 0.8×FY 2018: 1.8×FY 2019: 0.9×FY 2020: 0.9×FY 2021: -3.5×FY 2022: -3.0×FY 2023: 9.1×FY 2024: 1.0×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Interest Coverage -29.7×
FY 2016: -531762×FY 2017: -273×FY 2018: -89.6×FY 2019: -309×FY 2020: -167×FY 2021: 521×FY 2022: 0.0×FY 2023: -77.3×FY 2024: -194×FY 2025: -29.7×
FY 2016 5y median -29.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31